Virtus ETF Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $227K | Buy |
|
|||||
|
2025
Q2 | $41.5K | Hold |
|
|||||
|
2025
Q1 | $39.8K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $380K | Sell |
|
|||||
|
2021
Q2 | $496K | Buy |
|
|||||
|
2021
Q1 | $315K | Buy |
|
|||||
|
2020
Q4 | $316K | Sell |
|
|||||
|
2020
Q3 | $411K | Sell |
|
|||||
|
2020
Q2 | $356K | Buy |
|
|||||
|
2020
Q1 | $252K | Sell |
|
|||||
|
2019
Q4 | $395K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $751K | Buy |
|
|||||
|
2018
Q2 | $617K | Buy |
|
|||||
|
2018
Q1 | $754K | Buy |
|
|||||
|
2017
Q4 | $383K | Sell |
|
|||||
|
2017
Q3 | $321K | Buy |
|
|||||
|
2017
Q2 | $313K | Buy |
|
|||||
|
2017
Q1 | $372K | Buy |
|
|||||
|
2016
Q4 | $242K | Buy |
|